Connect with WHO Ethiopia

facebook-follow
 
twitter-follow

Ethiopia WHO Country Office

Print

  • WHO Donates Minilabs to Strengthen Control of SSFFC Substandard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products pose an unacceptable risk to public health. SSFFC medical products affect every region of the world, and all major therapeutic categories of medicines, including vaccines and diagnostics. They harm patients and undermine confidence in medical products, healthcare professionals and health systems. WHO conducts range of activities with Member States and stakeholders to minimize the risks from such products, including developing policies, identifying good practices, engaging in data collection and analysis…
  • Ethiopia Launchs a Pilot Human Papilloma Virus Vaccination Project In the quest to prevent cervical cancer, Ethiopia launched a pilot Human Papilloma Virus (HPV) vaccination pilot project in December 2015 targeting adolescent girls in the 9-13 year age group in Oromia and Tigray regions. The pilot project was implemented in Gomma Woreda (District) of Jimma Zone in Oromia Region, and Ahiferom Woreda (District) of Tigray Region. Girls in Grade 4 of the school system - in the 9-13 age group - were targeted in school-based administration of the vaccine, and…
  • mHealth Mobile Application Improves Access to Essential Surgical Care in Ethiopia In response to the need for access to life-saving surgical care, the World Health Organization's Emergency and Essential Surgical Care rogram has developed and launched the 'Integrated Management for Emergency and Essential Surgical Care'(IMEESC) toolkit via a mobile phone application. The toolkit will make available key resources in obstetric and surgical care literally at users’ fingertips. The IMEESC toolkit was launched in late November 2015 at the annual conference of the Ethiopian Surgical Society, which brought together surgeons, emergency surgical…
  • WHO Repurposes Ethiopia Country Office Staff for Emergency Response ADDIS ABABA, 28 December 2015 | The WHO Country Office, in collaboration with the Ethiopian Federal Ministry of Health (FMoH), conducted a one-day induction workshop on emergency response for its repurposed staff and consultants. In his opening remarks, Dr. Paul Mainuka, Acting WHO Representative to Ethiopia, highlighted that WHO is proactively engaged in working with the Government of Ethiopia to respond to the current emergency triggered by the El Niño weather phenomenon. “WHO internal Grade II Emergency has been declared as…
  • Mass Drug Administration to Deworm 17 Million Children Underway in Ethiopia Ethiopia has launched a large-scale nationwide mass drug administration (MDA) against soil-transmitted helminths (STH) and Schistosomiasis (also known as bilharzia), targeting 17 million school-aged children. The MDA aims to cover children aged 5-14 years, encompassing children enrolled in schools as well as those within the same age range but not enrolled in schools. The current MDA aims to cove 461 woredas (districts) in all 11 regions of the country. The MDA is being conducted using Mebendazole for STH and Praziquantel…

Ethiopia